IB Pharmaceuticals Inc. — Form D
IB Pharmaceuticals Inc. of RALEIGH, NC, a company, filed a Form D exempt-offering notice with the SEC on 2017-12-04. The offering totals $2.0M, of which $1.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-12-04
- Form: D
- Accession: 0001666690-17-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.4M
- Remaining: $550K
- Investors: 13
- Date of first sale: 2017-09-28
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-300009
Issuer
- Name: IB Pharmaceuticals Inc.
- CIK: 0001666690
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 8480 HONEYCUTT ROAD, RALEIGH, NC, 27615
- Phone: 919-275-1933
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Chris Prior | Executive Officer | Raleigh, NC |
| Jay Madan | Promoter | Raleigh, NJ |
| Sandeep Laumas | Director | Greenwich, CT |
| Sandeep Laumas | Executive Officer | Greenwich, CT |
| Jay Madan | Director | Raleigh, NJ |
| Jay Madan | Executive Officer | Raleigh, NJ |
| Christopher Prior | Executive Officer | Raleigh, NC |
| Christopher P Prior | Executive Officer | Raleigh, NC |
| Kendyle Woodard | Executive Officer | Raleigh, NC |
Other filings by this issuer (5)
More